Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    BSPM Gross Margin

    As of 2025-07-11, the Gross Margin of Biostar Pharmaceuticals Inc (BSPM) is 38.4%.

    Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

    BSPM Gross Margin - Historical Value
    DateValue
    2016-12-31 38.4%
    2015-12-31 40.9%
    2014-12-31 49.3%
    2013-12-31 48.7%
    2012-12-31 60.5%
    2011-12-31 70%
    2010-12-31 75%
    2009-12-31 73.2%
    2008-12-31 58.5%
    2007-12-31 67.1%
    BSPM Gross Margin - Peers Comparison
    TickerNameValue
    ACCAAcacia Diversified Holdings Inc4.9%
    ACUSAcusphere Inc-
    ATT.CNAbattis Bioceuticals Corp67.6%
    BIO.CNBiome Grow Inc20.5%
    CHM.CNChemistree Technology Inc25.5%
    CIG.CNCamarico Investment Group Ltd-155.7%
    CXUSCelexus Inc13.9%
    EAPHEaston Pharmaceuticals Inc12.9%
    ETSTEarth Science Tech Inc65.5%
    GENE.H.VInvictus MD Strategies Corp28.4%
    GSAC41.2%
    INTPIntegrated Pharmaceuticals Inc64.9%
    IPCI.TOIntellipharmaceutics International Inc100%
    KAYSKaya Holdings Inc-5.2%
    MDINNorthstar Global Business Services Inc50%
    NGBLNotis Global Inc-5.6%
    NOUVNouveau Life Pharmaceuticals Inc7775.2%
    NSHS.CNNanoSphere Health Sciences Inc7775.2%
    POT.CNPotent Ventures Inc6%
    PRVBProvention Bio Inc96%
    RCPIQRock Creek Pharmaceuticals Inc-49.6%
    RLSC.CNRise Life Science Corp6291.3%
    SIGOSunset Island Group Inc7775.2%
    SYUPANBC Inc-115.7%
    ULURAltrazeal Life Sciences Inc68%
    VOQPVioquest Pharmaceuticals Inc43.6%
    Tickers added to watchlist